|
|
|
|
| Symbol(s): |
BMRN |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
BMRN has a current Overall Rating of D (Negative). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| BMRN has a current Overall Rating of D (Negative). Power Rating (58) is neutral; appreciation potential (6) is negative. Relative to the S&P 500 Composite, BioMarin Pharmaceutical has slightly more Growth than Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. BMRN is of average investment quality. BMRN's current technical position is very strong. BMRN's Power Rating is 58. The trend in BMRN's earnings estimates has been unfavorable in recent...
| | |
|
|
